3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Dermatologic
1
Conditions
Neoplasms
10
Lung Neoplasms
9
Colorectal Neoplasms
7
Breast Neoplasms
7
Prostatic Neoplasms
6
Rectal Neoplasms
3
Polycystic Ovary Syndrome
3
Neoplasm Metastasis
3
Colonic Neoplasms
3
Stomach Neoplasms
2
Smoking Cessation
2
Neoplastic Cells, Circulating
2
Motor Activity
2
Lymphoma
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia
2
Endometrial Neoplasms
2
Disease
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Venous Thromboembolism
1
Vaginal Neoplasms
1
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer
1
Testicular Germ Cell Tumor
1
Stroke
1
Solitary Pulmonary Nodule
1
Skin Neoplasms
1
Sezary Syndrome
1
Interventions
Peripheral Blood Stem Cell Transplantation
36
fludarabine phosphate
33
Cyclophosphamide
31
Mycophenolic Acid
26
Whole-Body Irradiation
23
Tacrolimus
22
Cyclosporine
19
Radiotherapy
16
Busulfan
16
Antilymphocyte Serum
15
Methotrexate
14
Filgrastim
12
Etoposide
12
Flow Cytometry
11
Rituximab
8
Methylprednisolone
8
Melphalan
8
Brentuximab Vedotin
8
pembrolizumab
7
Therapeutics
7
Lenalidomide
7
Bortezomib
7
Psychiatric Rehabilitation
6
Gemcitabine
6
Cord Blood Stem Cell Transplantation
6
Bexarotene
6
romidepsin
5
mogamulizumab
5
fludarabine
5
Transplantation
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Mycosis Fungoides
×
Hematologic Tests
×
Clear all
NCT04904146
2025-03-10
BIO-MUSE
Lund University Hospital
Recruiting
120 enrolled